MSWM
RMD icon

Mowery & Schoenfeld Wealth Management’s ResMed RMD Stock Holding History

Mowery & Schoenfeld Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25
Closed -$5.63K – 382
2026
Q1 		$5.63K Hold
25
– – 0.01% 268
2025
Q4 		$6.04K Hold
25
– – 0.01% 305
2025
Q3 		$6.86K Hold
25
– – 0.01% 253
2025
Q2 		$6.47K Hold
25
– – 0.01% 250
2025
Q1 		$5.61K Sell
25
-3
-11% -$700 0.01% 317
2024
Q4 		$6.4K Buy
+28
New +$6.74K 0.01% 274

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mowery & Schoenfeld Wealth Management's RMD Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 25 shares — an estimated $5.63K sold.

Mowery & Schoenfeld Wealth Management first reported a position in RMD in Q4 2024 and held it in 6 quarters. The position peaked at $6.86K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Mowery & Schoenfeld Wealth Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Mowery & Schoenfeld Wealth Management sold 25 ResMed shares in Q2 2026, an estimated $5.63K.
  • Mowery & Schoenfeld Wealth Management first reported a position in ResMed in Q4 2024 and held it in 6 quarters.
  • Mowery & Schoenfeld Wealth Management's ResMed position peaked at $6.86K in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.